[Lecture Report] EU-Japan Webinar Series on COVID-19, Webinar N5. COVID-19 & Public Health Systems (Support Facility for the Implementation of the EU-Japan Strategic Partnership Agreement (SPA), July 30, 2020)
date : 8/18/2020
![[Lecture Report] EU-Japan Webinar Series on COVID-19, Webinar N5. COVID-19 & Public Health Systems (Support Facility for the Implementation of the EU-Japan Strategic Partnership Agreement (SPA), July 30, 2020)](https://hgpi.xsrv.jp/en/wp-content/uploads/sites/2/eyecatch_noritake-4.jpg)
On July 30th, HGPI CEO and Board Member Mr. Ryoji Noritake moderated a webinar in the EU-Japan Webinar Series on COVID-19 entitled “Webinar N5. COVID-19 & Public Health Systems,” hosted by the Support Facility for the Implementation of the EU-Japan Strategic Partnership Agreement (SPA).
This webinar was held in Japanese and English with simultaneous interpretation. The entire event has been released on YouTube.
The EU and Japan are committed to addressing cross-border health problems through cooperative efforts for disease prevention and control. In the context of the fight against the COVID-19 pandemic, measures to strengthen and reorganize public health services have been implemented in both regions. During the webinar, experts from Europe and Japan analyzed the impact of COVID-19 on the public health sector, examining topics such as budget and policy responses, trends, and projections.
For more information is available at
■Support Facility for the Implementation of the EU-Japan Strategic Partnership Agreement (SPA)
Top Research & Recommendations Posts
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Joint Report and Recommendations] “Rebalancing Health System: Innovation and Sustainability” A Joint Global Expert Meeting convened by the CSIS and HGPI